BVS - Bioventus Inc. (BVS) Q4 2023 Earnings Call Transcript

2024-03-12 11:00:27 ET

Bioventus Inc. (BVS)

Q4 2023 Earnings Conference Call

March 12, 2024, 08:30 AM ET

Company Participants

Dave Crawford - Vice President, Investor Relations

Rob Claypoole - President and Chief Executive Officer

Mark Singleton - Senior Vice President and Chief Financial Officer

Conference Call Participants

Chase Knickerbocker - Craig-Hallum Capital Group

Caitlin Cronin d - Canaccord Genuity

Presentation

Operator

Good day, and welcome to the Bioventus Inc. Fourth Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.

I would now like to turn the conference over to Dave Crawford, Vice President, Investor Relations. Please go ahead.

Dave Crawford

Thanks, Betsy, and good morning, everyone, and thanks for joining us. It is my pleasure to welcome you to the Bioventus 2023 fourth quarter earnings conference call. With me this morning are Rob Claypoole, CEO; and Mark Singleton, Senior Vice President and CFO. Rob will begin his remarks with his initial impressions and learning since joining as CEO and then lay out our priorities for 2024. Mark will provide detail on our fourth quarter and full year results and outline our 2024 financial guidance, we will finish the call with Q&A. The presentation for today's call is available on the Investors section of our website, bioventus.com.

But before we begin, I would like to remind everyone that our remarks today contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including the risks and uncertainties described in the company's filings with the SEC, including Item 1A Risk Factors of the company's Form 10-K for the year ended December 31, 2023, and as such factors may be updated from time to time in the company's other filings made with the Securities and Exchange Commission. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as the date made. Although it may voluntarily do so from time to time, the company undertakes no commitment to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities laws....

For further details see: